Skip to main content
Earnings Labs
EV

Evommune, Inc. (EVMN)

NYSE·Healthcare·Biotechnology

$6.67

+4.71%

Mkt Cap $244.25M

Analyst Ratings

Buy

5

Hold

3

Sell

0

Price Target (17 analysts)

$25.00

Range $8.00 – $50.00

Implied Upside

+274.8%

Consensus $25.00 vs current $6.67